Steroid-Modulated Proliferation of Human Endometrial Carcinoma Cell Lines: Any Role for Insulin-like Growth Factor Signaling?

Abstract

Objectives: Estrogen-stimulated proliferation of the normal and malignant human endometrium is balanced by the differentiating properties ofprogesterone. This study evaluated the role of insulin-like growth factor (IGF) signaling in steroid-induced modulation of endometrial cancer cell proliferation.

Methods: We used the human endometrial, estrogen-responsive ECC-1 and progesterone-responsive PRAB-36 cell lines. Proliferation studies with IGFs in combination with either estrogen orprogesterone were conducted. Furthermore, the mRNA and protein expression of insulin-like growth factor—binding proteins (IGFBPs) was evaluated.

Results: Using the ECC-1 cell line, we observed that estrogen-induced proliferation is modulated via the IGF-receptor signaling pathway, and that IGF-1-induced stimulation of prolferation does not influence estrogen receptor signaling. Furthermore, expression of the main modulators of IGF action, the IGFBPs, was found to be regulated by estrogen and progesterone in both cell lines. IGFBP-4 was up-regulated by estrogen in the ECC-1 cell line, and IGFBP-3 and IGFBP-6 were down-regulated by progesterone in the PRAB-36 cell line.

Conclusion: Estrogen-induced stimulation of prolferation of ECC-I endometrial cancer cells is partly achieved via IGF signaling. Furthermore, the IGFBPs are regulated by estrogens as well as progestagens and could potentially play a role in the modulation of endometrial cancer cell proliferation.

Keywords

Estrogen progesterone endometrium proliferation regulation IGF signaling IGFBP

Get full access to this article

View all access options for this article.

References

1. Van Gorp T , Neven P . Endometrial safety of hormone replacement therapy: Review of literature. Maturitas 2002;42:93-104.

2. Lentz SS . Advanced and recurrent endometrial carcinoma: Hormonal therapy. Semin Oncol 1994;21:100-106.

3. Rose PG . Endometrial carcinoma. N Engl J Med 1996;335:640-649.

4. Badinga L , Song S , Simmen RC , Clarke JB , Clemmons DR , Simmen FA . Complex mediation of uterine endometrial epithelial cell growth by insulin-like growth factor-Il (IGF-II) and IGF-binding protein-2. J Mol Endocrinol 1999;23:277-285.

5. Druckmann R , Rohr UD . IGF-1 in gynaecology and obstetrics: Update 2002. Maturitas 2002;41 Suppl 1:S65-S83.

6. Sara VR , Hall K . Insulin-like growth factors and their binding proteins. Physiol Rev 1990;70:591-614.

7. Rosenfeld RG , Lamson G , Pham H , et al. Insulinlike growth factor-binding proteins. Recent Prog Horm Res 1990; 46:99-159.

8. Hwa V , Oh Y , Rosenfeld RG . The insulin-like growth factor binding protein (IGFBP) superfamily. Endocr Rev 1999; 20:761-787.

9. LeRoith D , Werner H , Neuenschwander S , Kalebic T , Helman LJ . The role of the insuhn-like growth factor-I receptor in cancer. Ann N Y Acad Sci 1995;766:402-408.

10.

10. Nissley P , Lopaczynski W . Insulin-like growth factor receptors. Growth Factors 1991;5:29-43.

11.

11. Clenumons DR . Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 1997;8:45-62.

12.

12. Oh Y , Nagalla SR , Yamanaka Y , Kim HS , Wilson E , Rosenfeld RG . Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem 1996;271:30322-30325.

13.

13. Kelley KM , Oh Y , Gargosky SE , et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 1996;28:619-637.

14.

14. Zhou J , Dsupin BA , Giudice LC , Bondy CA . Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1994;79:1723-1734.

15.

15. Giudice LC , Milkowski DA , Lamson G , Rosenfeld RG , Irwin JC . Insulin-like growth factor binding proteins in human endometrium: Steroid-dependent messenger ribonucleic acid expression and protein synthesis. J Clin Endocrinol Metab 1991;72:779-787.

16.

16. Rutanen EM , Nyman T , Lehtovirta P , Ammala M , Pekonen F . Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: A molecular mechanism associating endometrial cancer with its risk factors. Int J Cancer 1994;59:307-312.

17.

17. Roy RN , Gerulath AH , Cecutti A , Bhavnani BR . Discordant expression of insulin-like growth factors and their receptor messenger ribonucleic acids in endometrial carcinomas relative to normal endometrium. Mol Cell Endocrnnol 1999;153:19-27.

18.

18. Kleinman D , Karas M , Roberts CT Jr , et al. Modulation of insulin-like growth factor I (IGF-I) receptors and membraneassociated IGF-binding proteins in endometrial cancer cells by estradiol. Endocrinology 1995;136:2531-2537.

19.

19. Pearl ML , Talavera F , Gretz HF 3rd , Roberts JA , Menon KM . Mitogenic activity of growth factors in the human endometrial adenocarcinoma cell lines HEC 1-A and KLE. Gynecol Oncol 1993;49:325-332.

20.

20. Satyaswaroop PG , Sivarajah A , Zaino RJ , Mortel R . Hormonal control of growth of human endometrial carcinoma in the nude mouse model. In: Bresciane F , King RJB , Lippman M , Raynaud JP , eds. Progress in cancer research and therapy. New York: Raven, 1988:430-435.

21.

21. Nishida M , Kasahara K , Oki A , Satoh T , Arai Y , Kubo T . Establishment of eighteen clones of Ishikawa cells. Hum Cell 1996;9:109-116.

22.

22. Blok LJ , De Ruiter PE , Kuhne EC , et al. Progestogenic effects of tibolone on human endometrial cancer cells. J Clin Endocrinol Metab 2003;88:2327-2334.

23.

23. Auffray C , Rougeon F . Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 1980;107:303-314.

24.

24. Blok LJ , Grossmann ME , Peny JE , Tindall DJ . Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol Endocrinol 1995;9(11):1610-1620.

25.

25. Rohlik QT , Adams D , Kull FC Jr , Jacobs S . An antibody to the receptor for insulin like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Commun 1987;149:276-281.

26.

26. Ayabe T , Tsutsumi O , Sakai H , et al. Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin like growth factor binding protein-1 in postmenopausal women with endometrial cancer. Endocr J 1997;44:419-424.

27.

27. Petridou E , Koukoulomatis P , Alexe DM , Voulgaris Z , Spanos E , Trichopoulos D . Endometrial cancer and the IGF system: a case control study in Greece. Oncology 2003;64:341-345.

28.

28. Maiorano E , Loverro G , Viale G , Giannini T , Napoli A , Perlino E . Insulin like growth factor-I expression in normal and diseased endometrium. Int J Cancer 1999;80:188-193.

29.

29. Adesanya OO , Zhou J , Samathanam C , Powell Braxton L , Bondy CA . Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle. Proc Natl Acad Sci U S A 1999;96:3287-3291.

30.

30. Klotz DM , Hewitt SC , Ciana P , et al. Requirement of estrogen receptor alpha in insulin like growth factor 1 (IGF 1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J Biol Chem 2002;277:8531-8537.

31.

31. Surmacz E , Burgaud JL . Overexpression of insulin receptor substrate 1 (IRS-i) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transfor mation. Clin Cancer Res 1995;1:1429-1436.

32.

32. Bartucci M , Morelli C , Mauro L , Ando S , Surmacz E . Differ ential insulin like growth factor I receptor signaling and function in estrogen receptor (ER) positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res 2001; 61:6747-6754.

33.

33. Neuenschwander S , Schwartz A , Wood TL , Roberts CT Jr , Hennighausen L , LeRoith D . Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest 1996;97:2225-2232.

34.

34. Murphy LJ , Molnar P , Lu X , Huang H . Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. J Mol Endocrinol 1995;15:293-303.

35.

35. Conover CA , Bale LK , Durham SK , Powell DR . Insulin-like growth factor (IGFI binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. Endocrinology 2000;141:3098-3103.

36.

36. Chen JC , Shao ZM , Sheikh MS , et al. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 1994;158:69-78.

37.

37. Martin JL , Weenink SM , Baxter RC . Insulin-like growth factor binding protein-3 potentiates epidermal growth factor action in MCF-1OA mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. J Biol Chem 2003;278:2969-2976.

38.

38. Mohseni-Zadeh S , Binoux M . Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: An alternative mechanism in the regulation of IGF action. Endocrinology 1997;138:5645-5648.

39.

39. Giudice LC , Conover CA , Bale L , et al. Identification and regulation ot the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: Evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab 2002;87:2359-2366.

40.

40. Rodgers BD , Strack AM , Dallman MF , Hwa L , Nicoll CS . Corricosrerone regulation of insulin-like growth factor I, IGF binding proteins, and growth in streptozotocin-induced diabetic rats. Diabetes 1995;44:1420-1425.

41.

41. Drivdahl RH , Loop SM , Andress DL , Ostenson RC . IGF binding proteins in human prostate tumor cells: Expression and regulation by 1,25-dihydroxyvitamin D3. Prostate 1995;26:72-79.

42.

42. Sheikh MS , Shao ZM , Hussain A , et al. Regulation of insulin like growth factor binding-protein-1, 2, 3, 4, 5, and 6: Synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. J Cell Physiol 1993;155:556-567.

43.

43. Singh P , Dai B , Yallampalli C , Xu Z . Expression of IGF-II and IGF binding proteins by colon cancer cells in relation to growtk response to IGFs. Am J Physiol 1904;267:G608-G617.

44.

44. Nordqvist AC , Mathiesen T . Expression of IGF-II, IGFBP 2,-5 and-6 in meningiomas with different brain invasiveness. J Neu rooncol 2002;57:19-26.